{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Skip Navigation
www.ahrq.gov
search
home
whatsnew
collection
primers
glossary
newsletter
mypsnet
newsletter
The Collection
>
Specific to High-Risk Drugs
PATIENT SAFETY PRIMERS
Narrow By
clear selections
Safety Target
< All
Specific to High-Risk Drugs
•
Anticoagulants (30)
•
Insulin (19)
•
Chemotherapeutic Agents (27)
•
Look-Alike, Sound-Alike Drugs (32)
•
Opiates/Narcotics (24)
Origin/Sponsor
•
Africa (2)
•
Asia (4)
•
Australia and New Zealand (3)
•
Central and South America (2)
•
Europe (25)
•
North America (145)
Resource Types
•
Audiovisual (3)
•
Book/Report (4)
•
Clinical Guideline (1)
•
Journal Article (120)
•
Legislation/Regulation (3)
•
Meeting/Conference (1)
•
Newspaper/Magazine Article (38)
•
Press Release/Announcement (12)
•
Special or Theme Issue (1)
•
Tools/Toolkit (3)
•
Web Resource (1)
Error Types
•
Epidemiology of Errors and Adverse Events (40)
•
Active Errors (78)
•
Latent Errors (19)
•
Near Miss (9)
Approach to Improving Safety
•
Quality Improvement Strategies (61)
•
Legal and Policy Approaches (8)
•
Error Reporting and Analysis (49)
•
Communication Improvement (38)
•
Human Factors Engineering (77)
•
Teamwork (4)
•
Specialization of Care (20)
•
Logistical Approaches (9)
•
Culture of Safety (6)
•
Technologic Approaches (54)
•
Education and Training (37)
Clinical Areas
•
Medicine (129)
•
Nursing (17)
•
Pharmacy (95)
Target Audience
•
Health Care Providers (168)
•
Health Care Executives and Administrators (139)
•
Non-Health Care Professionals (29)
•
Patients (16)
Setting of Care
•
Hospitals (116)
•
Psychiatric Facilities (1)
•
Residential Facilities (4)
•
Ambulatory Care (24)
•
Outpatient Surgery (1)
1 - 20
of 187
Show Excerpt
Don't Show Excerpt
Sort by relevance
Sort by significance
Sort by title
Sort by date
Sort by author
dropdown
STUDY
Drug formulations that require potentially inaccurate volumes to prepare doses for infants and children.
Uppal N, Yasseen B, Seto W, Parshuram CS. CMAJ. 2011;183:E246-E248.
STUDY
Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II.
Garrouste-Orgeas M, Timsit JF, Vesin A, et al; OUTCOMEREA Study Group. Am J Respir Crit Care Med. 2010:181:134-142.
STUDY
Medication-related patient safety incidents in critical care: a review of reports to the UK National Patient Safety Agency.
Thomas AN, Panchagnula U. Anaesthesia. 2008;63:726-733.
STUDY
NICU medication errors: identifying a risk profile for medication errors in the neonatal intensive care unit.
Stavroudis TA, Shore AD, Morlock L, Hicks RW, Bundy D, Miller MR. J Perinatol. 2010;30:459-468.
STUDY
Drug dosing error with drops – severe clinical course of codeine intoxication in twins.
Hermanns-Clausen M, Weinmann W, Auwärter V, et al. Eur J Pediatr. 2009;168:819-824.
STUDY
A multifaceted program for improving quality of care in intensive care units: IATROREF study.
Garrouste-Orgeas M, Soufir L, Tabah A, et al; Outcomerea Study Group. Crit Care Med. 2012;40:468-476.
COMMENTARY
ISMP medication error report analysis.
Cohen MR, Smetzer JL. Hosp Pharm. 2009;44:937-938, 945.
COMMENTARY
ISMP medication error report analysis.
Cohen MR, Smetzer JL. Hosp Pharm. 2010;45:282-287.
BOOK/REPORT
External Inquiry into the adverse incident that occurred at Queen's Medical Centre, Nottingham, 4th January 2001.
Toft B. London, England: Department of Health; 2001.
BOOK/REPORT
Vincristine: Learning from Error Workshop.
World Alliance for Patient Safety. Geneva, Switzerland: World Health Organization; 2008.
NEWSPAPER/MAGAZINE ARTICLE
Sterile water should not be given "freely."
PA-PSRS Patient Saf Advis. June 2008;5:53-56.
ORGANIZATIONAL POLICY/GUIDELINES
Vincristine (and other vinca alkaloids) should only be given intravenously via a minibag.
Information Exchange System Alert. Geneva, Switzerland: World Health Organization; July 18, 2007.
BOOK/REPORT
Fluorouracil Incident Root Cause Analysis Report.
Toronto, ON, Canada: Institute for Safe Medication Practices Canada. May 8, 2007.
STUDY
A comparison of voluntarily reported medication errors in intensive care and general care units.
Kane-Gill SL, Kowiatek JG, Weber RJ. Qual Saf Health Care. 2010;19:55-59.
NEWSPAPER/MAGAZINE ARTICLE
Drug package inserts get mixed reception.
Mitka M. JAMA. 2006;295:1110-1111.
COMMENTARY
Preparing your hospital for compliance with The Joint Commission's National Patient Safety Goals.
Murdaugh L, Jordin R. Hosp Pharm. 2008;43:728-733.
REVIEW
The safety of intravenous drug delivery systems: update on current issues since the 1999 Consensus Development Conference.
Sanborn M, Gabay M, Moody ML. Hosp Pharm. 2009;44:159-164.
COMMENTARY
The quest to eliminate intrathecal vincristine errors: a 40-year journey.
Noble DJ, Donaldson LJ. Qual Saf Health Care. 2010;19:323-326.
COMMENTARY
ISMP medication error report analysis.
Cohen MR. Hosp Pharm. 2008;43:960-964.
PRESS RELEASE/ANNOUNCEMENT
Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 10, 2011.
1
2
3
4
5
6
7
8
9
10
Next >